- Home
- VITL vs JANX Comparison
VITL vs JANX Comparison
Compare VITL & JANX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- VITL
- JANX
- Stock Information
- Founded
- VITL 2007
- JANX 2017
- Country
- VITL United States
- JANX United States
- Employees
- VITL N/A
- JANX N/A
- Industry
- VITL Packaged Foods
- JANX Biotechnology: Pharmaceutical Preparations
- Sector
- VITL Consumer Staples
- JANX Health Care
- Exchange
- VITL Nasdaq
- JANX Nasdaq
- Market Cap
- VITL 1.6B
- JANX 1.4B
- IPO Year
- VITL 2020
- JANX 2021
- Fundamental
- Price
- VITL $51.12
- JANX $23.98
- Analyst Decision
- VITL Strong Buy
- JANX Strong Buy
- Analyst Count
- VITL 9
- JANX 9
- Target Price
- VITL $48.67
- JANX $85.00
- AVG Volume (30 Days)
- VITL 1.2M
- JANX 745.4K
- Earning Date
- VITL 08-07-2025
- JANX 08-07-2025
- Dividend Yield
- VITL N/A
- JANX N/A
- EPS Growth
- VITL 5.37
- JANX N/A
- EPS
- VITL 1.13
- JANX N/A
- Revenue
- VITL $657,947,000.00
- JANX $439,000.00
- Revenue This Year
- VITL $29.99
- JANX N/A
- Revenue Next Year
- VITL $20.02
- JANX $591.60
- P/E Ratio
- VITL $45.39
- JANX N/A
- Revenue Growth
- VITL 21.49
- JANX N/A
- 52 Week Low
- VITL $27.91
- JANX $21.97
- 52 Week High
- VITL $53.13
- JANX $71.71
- Technical
- Relative Strength Index (RSI)
- VITL 63.83
- JANX 49.92
- Support Level
- VITL $48.94
- JANX $22.41
- Resistance Level
- VITL $52.79
- JANX $24.00
- Average True Range (ATR)
- VITL 2.04
- JANX 1.10
- MACD
- VITL -0.31
- JANX 0.01
- Stochastic Oscillator
- VITL 64.04
- JANX 42.20
About VITL Vital Farms Inc.
Vital Farms Inc is an ethical food company. The company retails pasture-raised eggs and butter. Its products include Pasture-Raised Eggs and Pasture-Raised Butter & Ghee. The company's purpose is rooted in a commitment to Conscious Capitalism, which prioritizes the long-term benefits of its stakeholders (farmers and suppliers, customers and consumers, communities and the environment, employees, and stockholders).
About JANX Janux Therapeutics Inc.
Janux Therapeutics Inc is a clinical-stage biopharmaceutical company developing tumor-activated immunotherapies for cancer. Its proprietary technology has enabled the development of two distinct bispecific platforms: Tumor Activated T Cell Engagers (TRACTr) and Tumor Activated Immunomodulators (TRACIr). The TRACTr platform produces T cell engagers (TCEs) with a tumor antigen-binding domain and a CD3 T cell binding domain, while the TRACIr platform produces bispecifics with a tumor antigen-binding domain and a costimulatory CD28 binding domain.